Not yet recruitingObservationalLast updated Aug 7, 2026

Anticipated Stigma, Illness Identity, and Quality of Life in Male Hypogonadism

The Impact of Anticipated Illness Stigma and Illness Identity on Quality of Life in Men With Hypogonadism: A Comparative Study With Other Chronic Endocrine Diseases

Overview

ClinicalTrials.gov ID: NCT07752511
Lead Sponsor: Hacettepe UniversityOTHER
Brief Summary: This study aims to systematically compare the levels of anticipated illness stigma and illness identity among men diagnosed with hypogonadism to those of men with other chronic endocrine conditions (e.g., diabetes mellitus, hypothyroidism, and hypertension). Furthermore, it examines whether these psychosocial variables predict quality-of-life deterioration specifically within the hypogonadism cohort.
Study Type

Status

Overall Status: Not yet recruiting
Start Date: Oct 1, 2026Estimated
Primary Completion Date: Oct 20, 2027Estimated
Completion Date: Oct 30, 2027Estimated

Study Record Dates

First Submitted: Aug 4, 2026
First Submitted that Met QC Criteria: Aug 4, 2026
First Posted: Aug 7, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 4, 2026
Last Update Posted: Aug 7, 2026Actual
Last Verified: Aug 2026

NCT03118479Terminated

Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)

NCT00254553Terminated

A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)

NCT04274036Unknown status

Evaluation of Stigma and Related Factors in Fibromyalgia

NCT07376239Completed

Quality of Life, Depression and Sexual Function in Men Living With HIV

NCT03176537Withdrawn

Periodontal Profile of Hypogonadic Men

NCT02171390Completed

Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy